Pharmacokinetics of chloramphenicol and chloramphenicol succinate in infants and children

J Pediatr. 1981 Feb;98(2):315-20. doi: 10.1016/s0022-3476(81)80670-1.


The metabolism and elimination of chloramphenicol-3-monosuccinate was studied in 45 infants and children, ages 3 days to 16 years, during intravenous administration. The apparent half-life of chloramphenicol was extremely variable, ranging from 1.7 to 12.0 hours with a mean of 5.1 hours. Apparent half-lives were inversely correlated with age. Chloramphenicol-S serum concentration declined biexponentially in most patients, with an estimated mean initial half-life of 0.7 hours and a subsequent longer mean half-life of 2.2 hours. Chloramphenicol-S persisted in serum up to six hours after a dose, and comprised a significantly larger fraction of total chloramphenicol in the serum of infants under one month of age than in older infants and children. A widely variable fraction of the administered chloramphenicol-S dose, with a mean of 33%, was excreted in the urine unchanged and was, therefore, not bioavailable in active form. Mean renal clearance of chloramphenicol-S was 259.5 ml/minute/1.73 M2, four times the mean creatinine clearance, indicating active tubular secretion. Variable hydrolysis and renal elimination of nonhydrolyzed chloramphenicol-S reduces the bioavailability of the antibiotic and appears to contribute substantially to the wide variation in apparent half-life and poor correlation between dose and serum concentration of free chloramphenicol.

MeSH terms

  • Adolescent
  • Biological Availability
  • Child
  • Child, Preschool
  • Chloramphenicol / administration & dosage
  • Chloramphenicol / analogs & derivatives*
  • Chloramphenicol / metabolism*
  • Creatinine / metabolism
  • Half-Life
  • Humans
  • Hydrolysis
  • Infant
  • Infant, Newborn
  • Kidney / metabolism
  • Kinetics
  • Metabolic Clearance Rate


  • Chloramphenicol
  • Creatinine
  • chloramphenicol succinate